Tags

Type your tag names separated by a space and hit enter

[Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
Brain Nerve. 2016 Jun; 68(6):607-15.BN

Abstract

Irritable bowel syndrome (IBS) is defined as a representative functional gastrointestinal disorder which is characterized by chronic or recurrent abdominal pain and/or abdominal discomfort associated with abnormal bowel movement. Gut microbiota are related to the pathophysiology of IBS. In the field of IBS, post-infectious etiology, stress-induced alteration of microbiota, increased mucosal permeability, bacterial overgrowth, disease-specific microbiota, microbial products, and brain-gut interactions are being investigated. In some individuals, IBS develops after recovery from acute gastroenteritis known as post-infectious IBS. Gut microbiota in IBS patients differ from those in healthy individuals, and the profiles of gut microbiota in IBS patients also vary among IBS patients with constipation, diarrhea, and mixed subtypes. In Japan, gut microbiota in IBS patients also differ from those observed in healthy individuals, and organic acid by-products observed in the patients correlated with symptoms, quality of life, and alexithymia. Further research on gut microbiota in IBS patients is warranted.

Authors+Show Affiliations

Department of Behavioral Medicine, Tohoku University Graduate School of Medicine.

Pub Type(s)

Journal Article

Language

jpn

PubMed ID

27279158

Citation

Fukudo, Shin. "[Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota]." Brain and Nerve = Shinkei Kenkyu No Shinpo, vol. 68, no. 6, 2016, pp. 607-15.
Fukudo S. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota]. Brain Nerve. 2016;68(6):607-15.
Fukudo, S. (2016). [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota]. Brain and Nerve = Shinkei Kenkyu No Shinpo, 68(6), 607-15. https://doi.org/10.11477/mf.1416200448
Fukudo S. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota]. Brain Nerve. 2016;68(6):607-15. PubMed PMID: 27279158.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota]. A1 - Fukudo,Shin, PY - 2016/6/10/entrez PY - 2016/6/10/pubmed PY - 2017/1/25/medline SP - 607 EP - 15 JF - Brain and nerve = Shinkei kenkyu no shinpo JO - Brain Nerve VL - 68 IS - 6 N2 - Irritable bowel syndrome (IBS) is defined as a representative functional gastrointestinal disorder which is characterized by chronic or recurrent abdominal pain and/or abdominal discomfort associated with abnormal bowel movement. Gut microbiota are related to the pathophysiology of IBS. In the field of IBS, post-infectious etiology, stress-induced alteration of microbiota, increased mucosal permeability, bacterial overgrowth, disease-specific microbiota, microbial products, and brain-gut interactions are being investigated. In some individuals, IBS develops after recovery from acute gastroenteritis known as post-infectious IBS. Gut microbiota in IBS patients differ from those in healthy individuals, and the profiles of gut microbiota in IBS patients also vary among IBS patients with constipation, diarrhea, and mixed subtypes. In Japan, gut microbiota in IBS patients also differ from those observed in healthy individuals, and organic acid by-products observed in the patients correlated with symptoms, quality of life, and alexithymia. Further research on gut microbiota in IBS patients is warranted. SN - 1881-6096 UR - https://www.unboundmedicine.com/medline/citation/27279158/[Irritable_Bowel_Syndrome_Emotion_Regulation_and_Gut_Microbiota]_ L2 - https://webview.isho.jp/openurl?rft.genre=article&rft.issn=1881-6096&rft.volume=68&rft.issue=6&rft.spage=607 DB - PRIME DP - Unbound Medicine ER -